Gram-negative rod bacteremia.
D000038:Abscess / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001806:Blood Urea Nitrogen; D002509:Cephaloridine / Q000627:therapeutic use*; D002761:Cholangitis / Q000188:drug therapy; D003091:Colistin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000139:chemically induced; D010538:Peritonitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011113:Polymyxins / Q000627:therapeutic use*; D012480:Salmonella Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D007612:Kanamycin; D002509:Cephaloridine; D003091:Colistin